Chemomab Therapeutics (CMMB) Shareholder's Equity Growth (3y) (2020 - 2025)
Chemomab Therapeutics (CMMB) Shareholder's Equity Growth (3y) (2020 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
| 10 |
Chemomab Therapeutics |
852.08 Mn |
841.71 Mn |
- |
| Date | Value |
|---|
| Dec 31, 2025 |
-30.17% |
| Sep 30, 2025 |
-36.86% |
| Jun 30, 2025 |
-42.80% |
| Mar 31, 2025 |
-43.37% |
| Dec 31, 2024 |
-39.61% |
| Sep 30, 2024 |
-37.08% |
| Jun 30, 2024 |
-47.25% |
| Mar 31, 2024 |
-37.71% |
| Dec 31, 2023 |
16.31% |
| Sep 30, 2023 |
14.07% |
| Jun 30, 2023 |
19.78% |
| Mar 31, 2023 |
37.62% |
| Dec 31, 2022 |
43.06% |
| Sep 30, 2022 |
29.81% |
| Jun 30, 2022 |
-23.58% |
| Mar 31, 2022 |
22.23% |
| Dec 31, 2021 |
84.39% |
| Sep 30, 2021 |
42.30% |
| Jun 30, 2021 |
43.40% |
| Dec 31, 2020 |
170.25% |
